- CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes
-
Min YH, Lee ST, Min DW, Kim TS, Lee CH, Lee BK, Hahn JS, Ko YW
- KMID: 1729610
- Yonsei Med J.
- 1995 Feb;36(1):1-8.
- doi: 10.3349/ymj.1995.36.1.1
Although it has been shown that the percentage of bone marrow blasts in myelodysplastic syndrome (MDS) constitute the only independent determinant of survival and progression to acute leukemia, the great... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3
-
Min YH, Lee ST, Lee BK, Chong SY, Lee S, Hahn JS, Ko YW
- KMID: 1729613
- Yonsei Med J.
- 1995 Feb;36(1):26-36.
- doi: 10.3349/ymj.1995.36.1.26
Stem cell factor (SCF), a c-kit ligand, has a preferential effect on the proliferation of several classes of immature hematopoietic progenitor cells in combination with GM-CSF or IL-3. To analyze... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunoreactivity of CD99 in Stomach Cancer
-
Jung KC, Park WS, Bae YM, Hahn JH, Hahn K, Lee H, Lee HW, Koo HJ, Shin HJ, Shin HS, Park YE, Park SH
- KMID: 1109756
- J Korean Med Sci.
- 2002 Aug;17(4):483-489.
- doi: 10.3346/jkms.2002.17.4.483
CD99 is characteristically expressed in Ewing's sarcoma/primitive neuroectodermal tumor. Recently its immunoreactivity has also been reported in other tumors. However, the significance of CD99 isoforms expressed in these tumors has... -
- CITED
-
- Close
- SHARE
-
- Close
